A clinical trial to study the effect of the drug Suringiyathi Chooranam for the management of patients with Sinusitis( Azhal thalainokkadu)
- Conditions
- Acute sinusitis, unspecified,
- Registration Number
- CTRI/2021/10/037652
- Lead Sponsor
- Government Siddha Medical College
- Brief Summary
This is a single non randomised open clinical trial to study the safety and efficacy of Suringiyathi Chooranam. The trial drug is given 2gms twice a day for 48days. The clinical trial is conducted after conducting pre clinical toxicity study. The trial drug Suringiyathi Chooranam is mentioned in Anuboga vaithiya Deva Ragasiyam.During the trial all the study related date will be recorded and documented. After the completion of trial all the data will be analysed statistically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
Rhinorrhoea Headache Pain and tenderness over para nasal sinus Recurrent sneezing Hyposmia or anosmia Nasal congestion.
Pregnancy and lactation Vasomotor rhinitis Opthalmic headache Migraine Otitis media.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is mainly assessed by reduction of clinical symptoms after 48 days and also assessed by Adelaide symptoms severity score Primary outcome is mainly assessed by reduction of clinical symptoms after 48 days and also assessed by Adelaide symptoms severity score
- Secondary Outcome Measures
Name Time Method Secondary outcome is mainly assessed by comparing the safety parameters before and after treatment 48days
Trial Locations
- Locations (1)
Aringar Anna Government Hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Aringar Anna Government Hospital of Indian Medicine🇮🇳Chennai, TAMIL NADU, IndiaDr Jayasri J MPrincipal investigator9843294118jayasrivishva84@gmail.com